Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Evaluation of Long-Time Decoction-Detoxicated Hei-Shun-Pian (Processed Aconitum carmichaeli Debeaux Lateral Root With Peel) for Its Acute Toxicity and Therapeutic Effect on Mono-Iodoacetate Induced Osteoarthritis. | Front Pharmacol | 2020 | 32848727 | PubTator, text mining | PubMed |
| Dioscin Attenuates Interleukin 1β (IL-1β)-Induced Catabolism and Apoptosis via Modulating the Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling in Human Nucleus Pulposus Cells. | Med Sci Monit | 2020 | 32841225 | PubTator, text mining | PubMed |
| Epigenetic mechanisms in Tendon Ageing. | Br Med Bull | 2020 | 32827252 | PubTator, text mining | PubMed |
| The Anti-ADAMTS-5 Nanobody® M6495 Protects Cartilage Degradation Ex Vivo. | Int J Mol Sci | 2020 | 32825512 | PubTator, text mining | PubMed |
| Recent progress on the role of miR-140 in cartilage matrix remodelling and its implications for osteoarthritis treatment. | Arthritis Res Ther | 2020 | 32811552 | PubTator, text mining | PubMed |
| Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols. | Biomed Pharmacother | 2020 | 32768946 | PubTator, text mining | PubMed |
| Lentinan Inhibits AGE-Induced Inflammation and the Expression of Matrix-Degrading Enzymes in Human Chondrocytes. | Drug Des Devel Ther | 2020 | 32764881 | PubTator, text mining | PubMed |
| Knockdown of TRIM8 Attenuates IL-1β-induced Inflammatory Response in Osteoarthritis Chondrocytes Through the Inactivation of NF-κB Pathway. | Cell Transplant | 2020 | 32757662 | PubTator, text mining | PubMed |
| Danon Disease-Associated LAMP-2 Deficiency Drives Metabolic Signature Indicative of Mitochondrial Aging and Fibrosis in Cardiac Tissue and hiPSC-Derived Cardiomyocytes. | J Clin Med | 2020 | 32751926 | PubTator, text mining | PubMed |
| Genetics in Cartilage Lesions: Basic Science and Therapy Approaches. | Int J Mol Sci | 2020 | 32751537 | PubTator, text mining | PubMed |
| Pathogenesis of Osteoarthritis: Risk Factors, Regulatory Pathways in Chondrocytes, and Experimental Models. | Biology (Basel) | 2020 | 32751156 | PubTator, text mining | PubMed |
| Vitamin D3 protects articular cartilage by inhibiting the Wnt/β-catenin signaling pathway. | Exp Ther Med | 2020 | 32742408 | PubTator, text mining | PubMed |
| Gene expression profiling in dorsolateral prostates of prepubertal and adult Sprague-Dawley rats dosed with estradiol benzoate, estradiol, and testosterone. | J Toxicol Sci | 2020 | 32741896 | PubTator, text mining | PubMed |
| Distinct Pattern of Inflammation of Articular Cartilage and the Synovium in Early and Late Hip Femoroacetabular Impingement. | Am J Sports Med | 2020 | 32736506 | PubTator, text mining | PubMed |
| Knee Osteoarthritis: A Review of Pathogenesis and State-Of-The-Art Non-Operative Therapeutic Considerations. | Genes (Basel) | 2020 | 32722615 | PubTator, text mining | PubMed |
| Interleukin-6 in Rheumatoid Arthritis. | Int J Mol Sci | 2020 | 32718086 | PubTator, text mining | PubMed |
| TRPV4 Inhibition and CRISPR-Cas9 Knockout Reduce Inflammation Induced by Hyperphysiological Stretching in Human Annulus Fibrosus Cells. | Cells | 2020 | 32708074 | PubTator, text mining | PubMed |
| The Emerging Role of Extracellular Vesicles in the Glioma Microenvironment: Biogenesis and Clinical Relevance. | Cancers (Basel) | 2020 | 32707733 | PubTator, text mining | PubMed |
| Injectable Biologics for the Treatment of Degenerative Disc Disease. | Curr Rev Musculoskelet Med | 2020 | 32705541 | PubTator, text mining | PubMed |
| Effects of the NF‑κB/p53 signaling pathway on intervertebral disc nucleus pulposus degeneration. | Mol Med Rep | 2020 | 32705171 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=52